BridgeMD
New treatment option for Hypertension
Official title Salt Intake and Blood Pressure Control in Adults With Essential Hypertension
ClinicalTrials.gov ID: NCT07025928
What this study is testing
- What it's testing
- The goal of this study is to explore the barriers and facilitators to adopting a reduced dietary salt and increased potassium intake among adults with essential hypertension in Singapore, and to evaluate the feasibility and preliminary effectiveness of a newly developed educational tool-Decreased Salt High Potassium (DSHP) Diet Tool-in reducing dietary sodium intake and increasing potassium intake. This three-part study will involve adults aged 21 years and above, with a self-reported diagnosis of hypertension for at least six months and/or currently taking antihypertensive medication.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older
You may be able to join if
- for patients:
- Participants who are 21 years old and above.
- Participants who self-reports to have hypertension for at least six months and/ or taking at least one type of antihypertensive medication daily for...
- Able to read English
You likely can't join if
- for patients:
- Participants with type 1/ type 2 or secondary diabetes mellitus
- Participants with CKD stage 3B and above
- Participants with serum potassium of above 4.5mmol/L (on the latest blood test)
- Participants with serum sodium of less than 135 mmol/L (on the latest blood test)
- Participants who are on daily potassium chloride
See the full eligibility criteria
- for patients:
- Participants who are 21 years old and above.
- Participants who self-reports to have hypertension for at least six months and/ or taking at least one type of antihypertensive medication daily for at least six months
- Able to read English
- for patients:
- Participants with type 1/ type 2 or secondary diabetes mellitus
- Participants with CKD stage 3B and above
- Participants with serum potassium of above 4.5mmol/L (on the latest blood test)
- Participants with serum sodium of less than 135 mmol/L (on the latest blood test)
- Participants who are on daily potassium chloride
- Participants who are on diuretics (thiazide or thiazide like diuretics)
- Participants who are pregnant
- Participants who had been diagnosed with any terminal illnesses, visually impaired, disability or mental health related illnesses (visually impaired refers to individuals who self-report to have difficulty reading the...
- Participants who are not clinically stable (Clinically stable patients are defined in this study as:
- Has clinic BP 100-160/60-100 mmHg, Heart Rate (HR) 60-100 bpm
- No recent hospitalizations (within the last 3 months) due to hypertensive emergencies, strokes, myocardial infarctions or other acute cardiovascular events
- No recent symptoms such as severe dizziness, fainting, or chest pain) \ Participants who are on PRN potassium supplements is not an exclusion criteria Inclusion criteria for Healthcare providers:
- HCPs who had prior experience in advising patients on dietary salt reduction
- HCPs who self-reported to have ever treated patients with hypertension Exclusion criteria for healthcare providers -nil
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore, Singapore
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.